204 related articles for article (PubMed ID: 16926143)
41. Autologous peripheral blood stem cell transplantation for POEMS syndrome.
Kuwabara S; Misawa S; Kanai K; Kikkawa Y; Nishimura M; Nakaseko C; Cho RK; Hattori T
Neurology; 2006 Jan; 66(1):105-7. PubMed ID: 16401856
[TBL] [Abstract][Full Text] [Related]
42. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
Haas R; Moos M; Möhle R; Döhner H; Witt B; Goldschmidt H; Murea S; Flentje M; Wannenmacher M; Hunstein W
Bone Marrow Transplant; 1996 Feb; 17(2):149-55. PubMed ID: 8640159
[TBL] [Abstract][Full Text] [Related]
43. Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation.
Barete S; Mouawad R; Choquet S; Viala K; Leblond V; Musset L; Amoura Z; Khayat D; Francès C
Arch Dermatol; 2010 Jun; 146(6):615-23. PubMed ID: 20566924
[TBL] [Abstract][Full Text] [Related]
44. Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL.
Flohr T; Hess G; Kolbe K; Gamm H; Nolte H; Stanislawski T; Huber C; Derigs HG
Bone Marrow Transplant; 2002 May; 29(9):769-75. PubMed ID: 12040475
[TBL] [Abstract][Full Text] [Related]
45. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.
Perz JB; Schonland SO; Hundemer M; Kristen AV; Dengler TJ; Zeier M; Linke RP; Ho AD; Goldschmidt H
Br J Haematol; 2004 Dec; 127(5):543-51. PubMed ID: 15566357
[TBL] [Abstract][Full Text] [Related]
46. High-dose etoposide plus granulocyte colony-stimulating factor as an effective chemomobilization regimen for autologous stem cell transplantation in patients with non-Hodgkin Lymphoma previously treated with CHOP-based chemotherapy: a study from the Consortium for Improving Survival of Lymphoma.
Hyun SY; Cheong JW; Kim SJ; Min YH; Yang DH; Ahn JS; Lee WS; Ryoo HM; Do YR; Lee HS; Lee JH; Oh SY; Suh C; Yhim HY; Kim JS
Biol Blood Marrow Transplant; 2014 Jan; 20(1):73-9. PubMed ID: 24141009
[TBL] [Abstract][Full Text] [Related]
47. Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells.
Knudsen LM; Gaarsdal E; Jensen L; Nielsen KJ; Nikolaisen K; Johnsen HE
J Hematother; 1996 Aug; 5(4):399-406. PubMed ID: 8877715
[TBL] [Abstract][Full Text] [Related]
48. Dramatic improvement of POEMS syndrome following autologous haematopoietic cell transplantation.
Rovira M; Carreras E; Bladé J; Graus F; Valls J; Fernández-Avilés F; Montserrat E
Br J Haematol; 2001 Nov; 115(2):373-5. PubMed ID: 11703338
[TBL] [Abstract][Full Text] [Related]
49. [POEMS syndrome: monoclonal plasma cell disorder with polyneuropathy].
Kamezaki K; Nagafuji K
Nihon Rinsho; 2007 Dec; 65(12):2235-7. PubMed ID: 18069266
[TBL] [Abstract][Full Text] [Related]
50. Autologous peripheral stem cell transplant for POEMS syndrome: a case report.
Gupta S; Rana V; Chandra D; Giralt SA; Juneja HS
Hematology; 2006 Oct; 11(5):361-3. PubMed ID: 17607587
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE
Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
[TBL] [Abstract][Full Text] [Related]
52. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
53. Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report.
Taenaka R; Shimokawa S; Katayama A; Nagao T; Obara T; Nishimura N; Tsujimoto A; Kohno K; Aoki K; Ogawa R
J Med Case Rep; 2022 Aug; 16(1):311. PubMed ID: 35978379
[TBL] [Abstract][Full Text] [Related]
54. What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?
Zhao H; Huang XF; Gao XM; Cai H; Zhang L; Feng J; Cao XX; Zhou DB; Li J
Leukemia; 2019 Apr; 33(4):1023-1029. PubMed ID: 30700844
[TBL] [Abstract][Full Text] [Related]
55. Mobilized peripheral blood progenitor cells (PBPC) in support of tandem cycles of high-dose chemotherapy (HDC).
Meisenberg BR; Miller WE; McMillan R
Bone Marrow Transplant; 1996 Dec; 18(6):1087-93. PubMed ID: 8971377
[TBL] [Abstract][Full Text] [Related]
56. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome.
Kuwabara S; Misawa S; Kanai K; Suzuki Y; Kikkawa Y; Sawai S; Hattori T; Nishimura M; Nakaseko C
Neurology; 2008 Nov; 71(21):1691-5. PubMed ID: 18832140
[TBL] [Abstract][Full Text] [Related]
57. Peripheral blood stem cell collection in children with acute leukemia: effectiveness of the 'DIAVE' mobilizing regimen.
Balduzzi A; Perseghin P; Dassi M; Bonanomi S; Rovelli A; Gaipa G; Biondi A; Uderzo C
Bone Marrow Transplant; 2002 Oct; 30(7):413-6. PubMed ID: 12368951
[TBL] [Abstract][Full Text] [Related]
58. POEMS syndrome treated with melphalan high-dose therapy and autologous blood stem cell transplantation: a single-institution experience.
Thoennissen GB; Thoennissen NH; Fritz F; Hilbig A; Kerkhoff A; Liersch R; Krug U; Koschmieder S; Müller-Tidow C; Mesters R; Kropff M; Berdel WE
Ann Hematol; 2012 Sep; 91(9):1419-25. PubMed ID: 22543828
[TBL] [Abstract][Full Text] [Related]
59. Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation.
Hovenga S; de Wolf JT; Guikema JE; Klip H; Smit JW; Smit Sibinga CT; Bos NA; Vellenga E
Bone Marrow Transplant; 2000 Apr; 25(7):723-8. PubMed ID: 10745257
[TBL] [Abstract][Full Text] [Related]
60. DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.
Mikesch JH; Kuhlmann M; Demant A; Krug U; Thoennissen GB; Schmidt E; Kessler T; Schliemann C; Pohlen M; Mohr M; Evers G; Köhler G; Wessling J; Mesters R; Müller-Tidow C; Berdel WE; Thoennissen NH
Ann Hematol; 2013 Aug; 92(8):1041-8. PubMed ID: 23532626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
